November 3, 2017 Life Science Tools

SeqLL Installs true Single Molecule Sequencing (tSMS®) Instrument to Support Oncology Research by Dr. David Ting, MD at the Harvard-MGH Cancer Center

November 03, 2017 07:45 AM Pacific Daylight Time WOBURN, Mass.–(BUSINESS WIRE)–SeqLL, LLC announced today that it has installed a true Single Molecule Sequencing (tSMS) Instrument at the Harvard-MGH Cancer Center to support oncology research conducted by Dr. David Ting, MD. Dr. Ting is Assistant Professor of Medicine at Harvard Medical School and a medical oncologist... Read more

July 11, 2017 Life Science Tools PR/Corporate

SeqLL Awarded SBIR to Advance the Development of Direct RNA Sequencing (DRS™) Technology

July 11, 2017 08:36 AM Pacific Daylight Time WOBURN, Mass.–(BUSINESS WIRE)–SeqLL, LLC announced today that it has been awarded a Phase I SBIR grant in the amount of $223,465 by the NIH/National Human Genome Research Institute to advance the development of Direct RNA Sequencing (DRS™) technology on SeqLL’s True Single Molecule Sequencing (tSMS™) platform. The... Read more

October 19, 2016 Life Science Tools Product Launch

SeqLL Launches Early Access Program for New true Single Molecule Sequencing (tSMS™) Benchtop System

Quantitative sequencing platform addresses limitations of other sequencing technologies October 19, 2016 06:42 AM Pacific Daylight Time WOBURN, Mass.–(BUSINESS WIRE)–SeqLL, LLC today announced the launch of the tSMS System Early Access Program giving researchers priority access to its proprietary quantitative sequencing platform. This benchtop system has been designed to deliver unparalleled quantitative RNA and specialty... Read more